Literature DB >> 24571055

New solvates of an old drug compound (phenobarbital): structure and stability.

Neslihan Zencirci1, Ulrich J Griesser, Thomas Gelbrich, Volker Kahlenberg, Ram K R Jetti, David C Apperley, Robin K Harris.   

Abstract

The solvent formation of phenobarbital, an important drug compound with an unusually complex polymorphic behavior, was studied in detail. Monosolvates with acetonitrile, nitromethane, dichloromethane, and 1,4-dioxane were produced and characterized by single-crystal and powder X-ray diffraction, thermoanalytical methods, FT-IR, Raman, and solid-state NMR spectroscopy. Thermal desolvation of these compounds yields mainly mixtures of polymorphs III, II, and I. At a low relative humidity (25 °C) the solvates transform to polymorph III, and at higher relative humidity the monohydrate and the metastable polymorphs IV and VI can be present as additional desolvation products. These results highlight the potential complexity of desolvation reactions and illustrate that a tight control of ambient conditions is a prerequisite for the production of phase-pure raw materials of drug compounds. Transformation in aqueous media results in the monohydrate. Below room temperature, the 1,4-dioxane monosolvate undergoes a reversible single-crystal-to-single-crystal phase transition due to the ordering/disordering of 50% of its solvent molecules. Dipolar-dephasing NMR experiments show that the solvent molecules are relatively mobile. Deuterium NMR spectra reinforce that conclusion for the dioxane solvent molecules. The crystal structure of an elusive 1,4-dioxane hemisolvate was also determined. This study clearly indicates the existence of "transient solvates" of phenobarbital. The formation of unstable phases of this kind must be considered in order to better understand how different solvents affect the crystallization of specific polymorphs.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24571055     DOI: 10.1021/jp409201v

Source DB:  PubMed          Journal:  J Phys Chem B        ISSN: 1520-5207            Impact factor:   2.991


  7 in total

1.  Theoretical explanation for the pharmaceutical incompatibility through the cooperativity effect of the drug-drug intermolecular interactions in the phenobarbital∙∙∙paracetamol∙∙∙H2O complex.

Authors:  Fei-Peng Zhai; Hong-En Wei; Yi Liu; Feng-Yun Hu
Journal:  J Mol Model       Date:  2019-06-07       Impact factor: 1.810

2.  Specific energy contributions from competing hydrogen-bonded structures in six polymorphs of phenobarbital.

Authors:  Thomas Gelbrich; Doris E Braun; Ulrich J Griesser
Journal:  Chem Cent J       Date:  2016-02-22       Impact factor: 4.215

3.  Buthalital and methitural - 5,5-substituted derivatives of 2-thio-barbituric acid forming the same type of hydrogen-bonded chain.

Authors:  Thomas Gelbrich; Ulrich J Griesser
Journal:  Acta Crystallogr E Crystallogr Commun       Date:  2017-11-21

4.  Combining X-ray and NMR Crystallography to Explore the Crystallographic Disorder in Salbutamol Oxalate.

Authors:  Aneesa J Al-Ani; Patrick M J Szell; Zainab Rehman; Helen Blade; Helen P Wheatcroft; Leslie P Hughes; Steven P Brown; Chick C Wilson
Journal:  Cryst Growth Des       Date:  2022-07-20       Impact factor: 4.010

5.  Crystal structure of 5-hy-droxy-5-propyl-barbituric acid.

Authors:  Thomas Gelbrich; Ulrich J Griesser
Journal:  Acta Crystallogr E Crystallogr Commun       Date:  2015-10-14

6.  The Hydrogen Bonded Structures of Two 5-Bromobarbituric Acids and Analysis of Unequal C5-X and C5-X' Bond Lengths (X = X' = F, Cl, Br or Me) in 5,5-Disubstituted Barbituric Acids.

Authors:  Thomas Gelbrich; Doris E Braun; Stefan Oberparleiter; Herwig Schottenberger; Ulrich J Griesser
Journal:  Crystals (Basel)       Date:  2016-04-22       Impact factor: 2.589

Review 7.  Can computed crystal energy landscapes help understand pharmaceutical solids?

Authors:  Sarah L Price; Doris E Braun; Susan M Reutzel-Edens
Journal:  Chem Commun (Camb)       Date:  2016-04-12       Impact factor: 6.222

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.